PLPietro Maria Lombardi

Pietro Maria Lombardi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pietro Maria Lombardi has a total of 155 co-authors. Here are the top co-authors by number of shared publications:

  • Giovanni Ferrari

    Division of Minimally Invasive Surgical Oncology, Niguarda Cancer Centre, ASST Grande Ospedale Metropolitano Niguarda , Milan

    6 shared publications
  • Michele Mazzola

    Division of Minimally Invasive Surgical Oncology, Niguarda Cancer Centre, ASST Grande Ospedale Metropolitano Niguarda , Milan

    5 shared publications
  • Monica Gualtierotti

    Division of Minimally Invasive Surgical Oncology, Niguarda Cancer Centre, ASST Grande Ospedale Metropolitano Niguarda , Milan

    5 shared publications
  • Paolo De Martini

    Division of Minimally Invasive Surgical Oncology, Niguarda Cancer Centre, ASST Grande Ospedale Metropolitano Niguarda , Milan

    4 shared publications
  • Vincenzo Nicastro

    Division of Minimally Invasive Surgical Oncology, Niguarda Cancer Centre, ASST Grande Ospedale Metropolitano Niguarda , Milan

    4 shared publications
  • Gian Luca Baiocchi

    Department of Clinical and Experimental Sciences, University of Brescia , Brescia

    3 shared publications

Latest Publications

  • Impact of indocyanine green on nodal dissection and staging for gastric cancer surgery: iGreenGO prospective multicentre study

    by Pietro Maria Lombardi, Michele Mazzola, Gian Luca Baiocchi, Francesca Bazzocchi, Felice Borghi, Carlo Castoro, Fabio Cianchi, Ugo Elmore, Federica Filippini, Gianluca Garulli, et al.

    Background: Lymphadenectomy is critical for accurate staging and prognostication of advanced gastric cancer. Indocyanine green (ICG) fluorescence imaging may optimize lymph node dissection but its applicability in Western patients is unclear. The aim of this study was to evaluate whether intraoperative ICG fluorescence is associated with change in surgical conduct (CSC) and stage migration during gastrectomy. Methods: This was a prospective, multicentre observational study (iGreenGO) conducted at 15 Italian referral centres. Patients with cT2–4a N0–3 M0 gastric adenocarcinoma undergoing minimally invasive distal or total gastrectomy with D2 lymphadenectomy were eligible. Endoscopic peritumoral ICG injection (2 ml at a concentration of 0.125 mg/ml) was performed within 20 h before surgery. The primary outcome was CSC, defined as additional tissue dissection prompted by residual fluorescence after standard white-light D2 lymphadenectomy. Results: A total of 316 patients (median age of 71.2 years; 185 male) were included between January 2022 and December 2024. The median number of dissected lymph nodes was 38 (interquartile range 29–47). CSC occurred in 61 patients (19.3%). Additional lymph nodes were retrieved in 47 of 61 patients (77.0%), with metastatic involvement in 10 of 47 patients (21.3%). Stage migration occurred in 3 of 316 patients (0.9%). ICG fluorescence showed a high false-positive rate for nodal metastases. Conclusion: Although ICG frequently led to additional dissection of nodal stations after standard white-light D2 lymphadenectomy, it rarely resulted in stage migration. Use of ICG fluorescence to optimize lymph node dissection likely does not have a clinically relevant benefit in Western patients with gastric cancer.

  • Comparison of surgical outcomes in laparoscopic gastrectomy for advanced gastric cancer between Japanese and Italian cohorts: an international, propensity score-matched investigation (the Shinkansen Study)

    by Pietro Maria Lombardi, Mitsumasa Yoshida, Gian Luca Baiocchi, Etsuro Bando, Alberto Biondi, Paolo De Martini, Stefano De Pascale, Federica Filippini, Gianluca Garulli, Simone Giacopuzzi, et al.


  • Totally robotic proximal gastrectomy with esophagogastrostomy using a double-flap technique

    by P. M. Lombardi, T. Kinoshita, M. Mazzola, G. Ferrari

    Proximal gastrectomy (PG) with D1 + lymphadenectomy and anti-reflux reconstruction is a standard surgical procedure for early-stage (EGC) proximal gastric cancer (PGC) in the East. The double-flap technique (DFT) for esophagogastrostomy has been established as an optimal anti-reflux reconstructive method after PG. However, its technical difficulty makes it a procedure not yet performed in the West. We present the technique of robotic PG with D1 + lymphadenectomy and DFT. The technique was learned during a period of attendance at the National Cancer Center Hospital East, Japan. A 70-year-old patient was submitted to endoscopic submucosal dissection for EGC-PGC. The pathologic report showed pT1b R1 disease. Additional surgery was recommended. Surgery was accomplished via a totally robotic approach (da Vinci Xi Surgical System). The patient was placed in a supine position with legs apart. Four robotic trocars and two laparoscopic trocars were placed above the transversal umbilical line. The surgical steps are summarized as follows: opening of the lesser omentum; dissection of the abdominal esophagus and lymphadenectomy of no. 1, 2 stations; partial omentectomy with lymphadenectomy of no. 4sa and 4sb stations and ligation of the left gastro-epiploic vessels; lymphadenectomy of no. 3a, 7, 8a, 9, 11p stations; transection of the esophagus; proximal gastrectomy; dissection of the posterior aspect of the remnant stomach; creation of the seromuscular flap; posterior esophageal suspension; anastomosis; flap closure. Pathology report showed the absence of residual disease with 27 lymph nodes collected from the specimen. After 1 year, the patient is disease free; no reflux esophagitis, weight loss, or anastomotic stricture was reported on follow-up. To the best of our knowledge, no other previous cases have been reported in the West describing the present surgical technique. The authors propose that PG with DFT seems feasible in a Western setting, representing an important and desirable skill for any referral center for gastric cancer surgical oncology.

  • Learning curve of laparoscopic cholecystectomy: a risk-adjusted cumulative summation (RA-CUSUM) analysis of six general surgery residents

    by Pietro Maria Lombardi, Michele Mazzola, Valentina Veronesi, Stefano Granieri, Stefano Piero Bernardo Cioffi, Marco Baia, Luca Del Prete, Davide Paolo Bernasconi, Piergiorgio Danelli, Giovanni Ferrari

    Background Laparoscopic cholecystectomy (LapC) is one of the most frequently performed surgical procedures worldwide. Reaching technical competency in performing LapC is considered one essential task for young surgeons. Investigating the learning curve for LapC (LC-LapC) may provide important information regarding the learning process and guide the training pathway of residents, improving educational outcomes. The present study aimed to investigate LC-LapC among general surgery residents (GSRs). Methods Operative surgical reports of consecutive patients undergoing LapC performed by GSRs attending the General Surgery Residency Program at the University of Milan were analysed. Data on patient- and surgery-related variables were obtained from the ICD-9-CM diagnosis codes and gathered. A multidimensional assessment of the LC was performed through Cumulative Sum (CUSUM) and Risk-Adjusted (RA)-CUSUM analysis. Results 340 patients operated by 6 GSRs were collected. The CUSUM and RA-CUSUM graphs based on surgical failures allowed to distinguish two defined phases for all GSRs: an initial phase ending at the peak, so-called learning phase, followed by a phase in which there was a significant decrease in failure incidence, so-called proficiency phase. The learning phase was completed for all GSRs at most within 25 procedures, but the trend of the curves and the number of procedures needed to achieve technical competency varied among operators ranging between 7 and 25. Conclusions The present study suggested that at most 25 procedures might be sufficient to acquire technical competency in LapC. The variability in the number of procedures needed to complete the LC, ranging between 7 and 25, could be due to the heterogeneous scenarios in which LapC was performed, and deserves to be investigated through a prospective study involving a larger number of GSRs and institutions. Graphical abstract


  • Open versus laparoscopic gastrectomy for advanced gastric cancer: a propensity score matching analysis of survival in a western population—on behalf of the Italian Research Group for Gastric Cancer

    by Pietro Maria Lombardi, D. Bernasconi, G.L. Baiocchi, M. Berselli, A. Biondi, C. Castoro, M. Catarci, M. Degiuli, U. Fumagalli Romario, S. Giacopuzzi, et al.

    Background Oncologic outcomes after laparoscopic gastrectomy for advanced gastric cancer in the West have been poorly investigated. The aim of the present study was to compare survival outcomes in patients undergoing curative-intent laparoscopic and open gastrectomy for advanced gastric cancer in several centres belonging to the Italian Research Group for Gastric Cancer. Methods Data of patients operated between 2015 and 2018 were retrospectively analysed. Propensity Score Matching was performed to balance baseline characteristics of patients undergoing laparoscopic and open gastrectomy. The primary endpoint was 3-year overall survival. Secondary endpoints were 3-year disease-free survival and short-term outcomes. Multivariable regression analyses for survival were conducted. Results Data were retrieved from 20 centres. Of the 717 patients included, 438 patients were correctly matched, 219 per group. The 3-year overall survival was 73.6% and 68.7% in the laparoscopic and open group, respectively (p = 0.40). When compared with open gastrectomy, laparoscopic gastrectomy showed comparable 3-year disease-free survival (62.8%, vs 58.9%, p = 0.40), higher rate of return to intended oncologic treatment (56.9% vs 40.2%, p = 0.001), similar 30-day morbidity/mortality. Prognostic factors for survival were ASA Score ≥ 3, age-adjusted Charlson Comorbidity Index ≥ 5, lymph node ratio ≥ 0.15, p/ypTNM Stage III and return to intended oncologic treatment. Conclusions Laparoscopic gastrectomy for advanced gastric cancer offers similar rates of survival when compared to open gastrectomy, with higher rates of return to intended oncologic treatment. ASA score, age-adjusted Charlson Comorbidity Index, lymph node ratio, return to intended oncologic treatment and p/ypTNM Stage, but not surgical approach, are prognostic factors for survival.


  • Open Access

    The iGreenGO Study: The Clinical Role of Indocyanine Green Imaging Fluorescence in Modifying the Surgeon’s Conduct During the Surgical Treatment of Advanced Gastric Cancer—Study Protocol for an International Multicenter Prospective Study

    by Pietro Maria Lombardi, Michele Mazzola, Vincenzo Nicastro, Simone Giacopuzzi, Gian Luca Baiocchi, Carlo Castoro, Riccardo Rosati, Uberto Fumagalli Romario, Luigi Bonavina, Fabio Staderini, et al.

    Background: The near-infrared/indocyanine green imaging fluorescence (NIR/ICG) technology is showing promising results in several fields of surgical oncology. The clinical value of NIR/ICG technology in the surgical treatment of advanced gastric cancer (AGC) is not clearly established. Methods: This is the protocol of the “iGreenGO” (indocyanine Green Gastric Observation) Study, a national prospective multicenter study. Western patients who undergo curative-intent gastrectomy with D2 lymphadenectomy for AGC constitute the study cohort. All the patients undergo preoperative upper gastrointestinal endoscopy for submucosal peritumoral ICG injection at the most 20 h before surgery. Intraoperative endoscopic injection before starting surgical dissection is also allowed. The primary endpoint is the “change in the surgical conduct” (CSC), i.e., the need to perform further dissection after intraoperative NIR/ICG technology activation at the end of D2 lymphadenectomy. Secondary endpoints include the pattern of abdominal fluorescence distribution according to tumor and patient characteristics, the preoperative clinical variables potentially associated with CSC, and the incidence of stage migration due to NIR/ICG application. Discussion: The iGreenGO Study is the first study to investigate the clinical role of NIR/ICG technology for the surgical treatment of AGC in a large cohort of Western patients. Results from the present study can further clarify the role of NIR/ICG technology in surgical lymphadenectomy for AGC.


  • Single Anastomosis Duodenoileal Bypass with Sleeve Gastrectomy for Morbid Obesity: A Step-by-Step Video Technique

    by Valerio Girardi, Pietro Maria Lombardi, Vincenzo Nicastro, Antonello Forgione, Monica Gualtierotti, Gisella Barone, Paolo De Martini, Carmelo Magistro, Camillo Leonardo Bertoglio, Michele Mazzola, et al.

    Introduction: Single anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S), a modification of biliopancreatic diversion with duodenal switch, reduces the number of anastomoses and lengthens the common limb, mitigating short- and long-term complications related to other bilio-diverting procedures.1 As recently reported, SADI-S achieves and maintains significant weight loss along with improvements in metabolic health.2 However, it is a technically demanding procedure requiring extensive experience in bariatric and minimally invasive surgery.3 This video reports a step-by-step SADI-S technique, performed on a 49-year-old male, with a body mass index (BMI) of 48 kg/m2 and multiple comorbidities including type 2 diabetes and hypertension. Methods: The patient is placed in a supine position, with legs apart, with the first surgeon positioned between the legs and one assistant on each side of the patient's abdomen. Six ports are placed as follows: a 12 mm trocar along the midline, 15 cm below the xiphoid process and 3 cm on the left side; 15 and 12 mm trocars at the same level on the right and left sides along the midclavicular lines; two 5 mm trocars along the anterior axillary lines along the costal margin bilaterally and symmetrically; and the last 5 mm trocar in the subxiphoid position. A sleeve gastrectomy is performed starting 6 cm from the pylorus and proceeding until the gastric fundus and the left diaphragmatic crus is divided (UltraCision, Ethicon Endosurgery, Cincinnati, OH). The gastric tube is fashioned on a calibrated probe of at least 45 Fr, using 60 mm staplers reinforced with polyglycolic acid. The pylorus and the first part of the duodenum are isolated, using the gastroduodenal artery as a landmark for dissection. The duodenum is transected 2–3 cm distal to pylorus. The first surgeon moves to the patient's left side. The small bowel is measured 250 cm from the ileocecal valve. A duodenoileal end-to-side hand-sewn anastomosis is fashioned with double-strand adsorbable running suture. An air-blue test is performed. Specimen extraction was done by minilaparotomy at the left 15 mm trocar. Results: Operative time was 190 minutes without intra-/postoperative complications. Clear liquids were given on postoperative day (POD) 1. Upper gastrointestinal series was obtained on POD 2, before starting a soft diet. Nutritional evaluation was provided before patient's discharge, which occurred on POD 5. Outpatient care included follow-up at 1, 3, 6, 9, and 12 months. After 12 months, the patient achieved a weight loss of 67 kg, with a final BMI of 20.7 kg/m2 and his medications for hypertension and diabetes were discontinued. He had no nutritional deficiencies. Conclusion: Owing to its technical features, we recommend bariatric surgeons and their multidisciplinary teams undertake extensive technical and medical training before embarking in SADI-S. A larger experience is needed to determine the role of this technique as a primary or conversion bariatric surgery. Source of Work: Video article of surgical practice. Additional Declarations: No previous presentations of this abstract occurred. Acknowledgment: The authors thank Letizia Maria Lasi for her valuable contribution to video editing. No competing financial interests exist. Runtime of video: 9 mins 20 secs

  • ERAS pathway for gastric cancer surgery: adherence, outcomes and prognostic factors for compliance in a Western centre

    by Pietro Maria Lombardi, Michele Mazzola, Alessandro Giani, Sara Baleri, Marianna Maspero, Paolo De Martini, Monica Gualtierotti, Giovanni Ferrari

    Adherence to an ERAS program guarantees an evidence-based approach for patient care, but the compliance to ERAS in patients undergoing surgery for gastric cancer in Western countries has not been clearly investigated. Our Institution has implemented an ERAS pathway (EP) for gastric surgery, composed of 24 items, since December 2016. We retrospectively analyzed the data of all consecutive patients undergoing surgery with curative intent for gastric cancer between January 2017 and December 2019 at our Institution, and were eligible for our EP. The primary endpoint was patients’ compliance to the EP. Secondary endpoints were patients’ adherence to each ERAS item and detection of variables associated with compliance failure. Seventy-three patients were included. Among these, 75.3% completed the EP, with a median number of items accomplished per patient of 21. Items with critical adherence were restrictive intraoperative fluid infusion (37%), avoidance of abdominal drain (14%), first clear liquid intake (67%), first solid food intake (48%). At univariate analysis age > 75 years, ASA > 2 and total gastrectomy were associated with failure to complete the EP. At multivariate analysis, ASA Score > 2 was the only preoperative factor associated with EP failure. Application of an ERAS program for malignant gastric surgery seems to be feasible with an acceptable completion rate in a tertiary referral Western centre. Preoperative factors, such as old age, advanced stage at diagnosis and neoadjuvant chemotherapy should not be considered as exclusion criteria for ERAS.


  • Open Access

    Ampullary Adenocarcinoma with Incidental Pancreatic Neuroendocrine Tumor: Report of an Extremely Rare Case and Review of Literature

    by Matteo Viti, Pietro Maria Lombardi, Mattia Marinelli, Monica Onorati, Corrado D'Urbano

    Periampullary neoplasms are a heterogeneous group of tumors arising within 2 cm of the ampulla of Vater. Neuroendocrine tumors can originate throughout the entire body, from neuroendocrine cells. These neoplasms exhibit deep differences, according to their origin and biological behavior. We describe a case of a 79-year-old man who underwent pancreaticoduodenectomy for adenocarcinoma of the ampulla of Vater after proper staging. At gross histology, an incidental pancreatic neuroendocrine tumor was also documented. Despite two synchronous neoplasms, the patient survived 34 months with no evidence of recurrence at follow-up. The synchronous presence of a second primitive tumor in patients affected by a neuroendocrine tumor is reported in the literature; incidence is variable and the most common site is the gastrointestinal tract. Diagnostic workup for ampullary neoplasms includes abdominal computed tomography (CT) scan, magnetic resonance imaging (MRI) and endoscopic ultrasound (EUS). These investigations infrequently may detect subcentimetric lesions. We believe this case is currently extremely rare. Preoperative diagnosis of synchronous PanNET would not have changed our approach since surgical therapy represents the gold standard in resectable ampullary neoplasms, and it has a primary role in the prognosis of the present patient.